Static Magnetic Field Therapy for Carpal Tunnel Syndrome: A Feasibility Study

Agatha P. Colbert, Marko S. Markov, Nels Carlson, William L. Gregory, Hans Carlson, Patricia J. Elmer

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Colbert AP, Markov MS, Carlson N, Gregory WL, Carlson H, Elmer PJ. Static magnetic field therapy for carpal tunnel syndrome: a feasibility study. Objectives: To assess the feasibility of conducting trials of static magnetic field (SMF) therapy for carpal tunnel syndrome (CTS), to collect preliminary data on the effectiveness of 2 SMF dosages, and to explore the influence of an SMF on median nerve conduction. Design: Randomized, double-blind, sham-controlled trial with a 6-week intervention and a 12-week follow-up. Setting: University hospital outpatient clinics. Participants: Women and men (N=60), ages 21 to 65 years, with an electrophysiologically confirmed CTS diagnosis recruited from the general population. Interventions: Participants wore nightly either neodymium magnets that delivered either 15 or 45mTesla (mT) to the contents of the carpal canal or a nonmagnetic disk. Main Outcome Measures: Symptom Severity Scale (SSS) and Function Severity Scale (FSS) of the Boston Carpal Tunnel Questionnaire (BCTQ) and 4 median nerve parameters: sensory distal latency, sensory nerve action potential amplitude, motor distal latency and compound motor action potential amplitude. Results: Fifty-eight of 60 randomized participants completed the study. There were no significant between-group differences for change in the primary endpoint SSS or for FSS or median nerve conduction parameters. For the SSS and the FSS, each group showed a reduction at 6 weeks indicating improvement in symptoms. Conclusions: This study showed the feasibility and safety of testing SMF therapy for CTS. There were no between-group differences observed for the BCTQ or median nerve parameters after 6 weeks of SMF therapy. Significant within-group, symptomatic improvements of the same magnitude were experienced by participants in both active and sham magnet groups. Future studies are needed to optimize SMF dosimetry and resolve issues related to the use of sham controls in SMF trials.

Original languageEnglish (US)
Pages (from-to)1098-1104
Number of pages7
JournalArchives of Physical Medicine and Rehabilitation
Volume91
Issue number7
DOIs
StatePublished - Jul 2010

Fingerprint

Magnetic Field Therapy
Carpal Tunnel Syndrome
Median Nerve
Feasibility Studies
Magnetic Fields
Wrist
Magnets
Neural Conduction
Action Potentials
Hospital Outpatient Clinics
Neodymium
Outcome Assessment (Health Care)
Safety
Population

Keywords

  • Carpal tunnel syndrome
  • Magnetic field therapy
  • Magnetics
  • Rehabilitation

ASJC Scopus subject areas

  • Rehabilitation
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Static Magnetic Field Therapy for Carpal Tunnel Syndrome : A Feasibility Study. / Colbert, Agatha P.; Markov, Marko S.; Carlson, Nels; Gregory, William L.; Carlson, Hans; Elmer, Patricia J.

In: Archives of Physical Medicine and Rehabilitation, Vol. 91, No. 7, 07.2010, p. 1098-1104.

Research output: Contribution to journalArticle

Colbert, Agatha P. ; Markov, Marko S. ; Carlson, Nels ; Gregory, William L. ; Carlson, Hans ; Elmer, Patricia J. / Static Magnetic Field Therapy for Carpal Tunnel Syndrome : A Feasibility Study. In: Archives of Physical Medicine and Rehabilitation. 2010 ; Vol. 91, No. 7. pp. 1098-1104.
@article{2652d0df1e5f457a97f862fab1077900,
title = "Static Magnetic Field Therapy for Carpal Tunnel Syndrome: A Feasibility Study",
abstract = "Colbert AP, Markov MS, Carlson N, Gregory WL, Carlson H, Elmer PJ. Static magnetic field therapy for carpal tunnel syndrome: a feasibility study. Objectives: To assess the feasibility of conducting trials of static magnetic field (SMF) therapy for carpal tunnel syndrome (CTS), to collect preliminary data on the effectiveness of 2 SMF dosages, and to explore the influence of an SMF on median nerve conduction. Design: Randomized, double-blind, sham-controlled trial with a 6-week intervention and a 12-week follow-up. Setting: University hospital outpatient clinics. Participants: Women and men (N=60), ages 21 to 65 years, with an electrophysiologically confirmed CTS diagnosis recruited from the general population. Interventions: Participants wore nightly either neodymium magnets that delivered either 15 or 45mTesla (mT) to the contents of the carpal canal or a nonmagnetic disk. Main Outcome Measures: Symptom Severity Scale (SSS) and Function Severity Scale (FSS) of the Boston Carpal Tunnel Questionnaire (BCTQ) and 4 median nerve parameters: sensory distal latency, sensory nerve action potential amplitude, motor distal latency and compound motor action potential amplitude. Results: Fifty-eight of 60 randomized participants completed the study. There were no significant between-group differences for change in the primary endpoint SSS or for FSS or median nerve conduction parameters. For the SSS and the FSS, each group showed a reduction at 6 weeks indicating improvement in symptoms. Conclusions: This study showed the feasibility and safety of testing SMF therapy for CTS. There were no between-group differences observed for the BCTQ or median nerve parameters after 6 weeks of SMF therapy. Significant within-group, symptomatic improvements of the same magnitude were experienced by participants in both active and sham magnet groups. Future studies are needed to optimize SMF dosimetry and resolve issues related to the use of sham controls in SMF trials.",
keywords = "Carpal tunnel syndrome, Magnetic field therapy, Magnetics, Rehabilitation",
author = "Colbert, {Agatha P.} and Markov, {Marko S.} and Nels Carlson and Gregory, {William L.} and Hans Carlson and Elmer, {Patricia J.}",
year = "2010",
month = "7",
doi = "10.1016/j.apmr.2010.02.013",
language = "English (US)",
volume = "91",
pages = "1098--1104",
journal = "Archives of Physical Medicine and Rehabilitation",
issn = "0003-9993",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - Static Magnetic Field Therapy for Carpal Tunnel Syndrome

T2 - A Feasibility Study

AU - Colbert, Agatha P.

AU - Markov, Marko S.

AU - Carlson, Nels

AU - Gregory, William L.

AU - Carlson, Hans

AU - Elmer, Patricia J.

PY - 2010/7

Y1 - 2010/7

N2 - Colbert AP, Markov MS, Carlson N, Gregory WL, Carlson H, Elmer PJ. Static magnetic field therapy for carpal tunnel syndrome: a feasibility study. Objectives: To assess the feasibility of conducting trials of static magnetic field (SMF) therapy for carpal tunnel syndrome (CTS), to collect preliminary data on the effectiveness of 2 SMF dosages, and to explore the influence of an SMF on median nerve conduction. Design: Randomized, double-blind, sham-controlled trial with a 6-week intervention and a 12-week follow-up. Setting: University hospital outpatient clinics. Participants: Women and men (N=60), ages 21 to 65 years, with an electrophysiologically confirmed CTS diagnosis recruited from the general population. Interventions: Participants wore nightly either neodymium magnets that delivered either 15 or 45mTesla (mT) to the contents of the carpal canal or a nonmagnetic disk. Main Outcome Measures: Symptom Severity Scale (SSS) and Function Severity Scale (FSS) of the Boston Carpal Tunnel Questionnaire (BCTQ) and 4 median nerve parameters: sensory distal latency, sensory nerve action potential amplitude, motor distal latency and compound motor action potential amplitude. Results: Fifty-eight of 60 randomized participants completed the study. There were no significant between-group differences for change in the primary endpoint SSS or for FSS or median nerve conduction parameters. For the SSS and the FSS, each group showed a reduction at 6 weeks indicating improvement in symptoms. Conclusions: This study showed the feasibility and safety of testing SMF therapy for CTS. There were no between-group differences observed for the BCTQ or median nerve parameters after 6 weeks of SMF therapy. Significant within-group, symptomatic improvements of the same magnitude were experienced by participants in both active and sham magnet groups. Future studies are needed to optimize SMF dosimetry and resolve issues related to the use of sham controls in SMF trials.

AB - Colbert AP, Markov MS, Carlson N, Gregory WL, Carlson H, Elmer PJ. Static magnetic field therapy for carpal tunnel syndrome: a feasibility study. Objectives: To assess the feasibility of conducting trials of static magnetic field (SMF) therapy for carpal tunnel syndrome (CTS), to collect preliminary data on the effectiveness of 2 SMF dosages, and to explore the influence of an SMF on median nerve conduction. Design: Randomized, double-blind, sham-controlled trial with a 6-week intervention and a 12-week follow-up. Setting: University hospital outpatient clinics. Participants: Women and men (N=60), ages 21 to 65 years, with an electrophysiologically confirmed CTS diagnosis recruited from the general population. Interventions: Participants wore nightly either neodymium magnets that delivered either 15 or 45mTesla (mT) to the contents of the carpal canal or a nonmagnetic disk. Main Outcome Measures: Symptom Severity Scale (SSS) and Function Severity Scale (FSS) of the Boston Carpal Tunnel Questionnaire (BCTQ) and 4 median nerve parameters: sensory distal latency, sensory nerve action potential amplitude, motor distal latency and compound motor action potential amplitude. Results: Fifty-eight of 60 randomized participants completed the study. There were no significant between-group differences for change in the primary endpoint SSS or for FSS or median nerve conduction parameters. For the SSS and the FSS, each group showed a reduction at 6 weeks indicating improvement in symptoms. Conclusions: This study showed the feasibility and safety of testing SMF therapy for CTS. There were no between-group differences observed for the BCTQ or median nerve parameters after 6 weeks of SMF therapy. Significant within-group, symptomatic improvements of the same magnitude were experienced by participants in both active and sham magnet groups. Future studies are needed to optimize SMF dosimetry and resolve issues related to the use of sham controls in SMF trials.

KW - Carpal tunnel syndrome

KW - Magnetic field therapy

KW - Magnetics

KW - Rehabilitation

UR - http://www.scopus.com/inward/record.url?scp=77953849531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953849531&partnerID=8YFLogxK

U2 - 10.1016/j.apmr.2010.02.013

DO - 10.1016/j.apmr.2010.02.013

M3 - Article

C2 - 20599049

AN - SCOPUS:77953849531

VL - 91

SP - 1098

EP - 1104

JO - Archives of Physical Medicine and Rehabilitation

JF - Archives of Physical Medicine and Rehabilitation

SN - 0003-9993

IS - 7

ER -